LFCR Q3 2025 Earnings — Lifecore Biomedical, Inc. Revenue & Financial Results | Market Cap Arena

LFCRLifecore Biomedical, Inc.

$267M

Q3 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$35M-1.5% YoY

Gross Profit

$10M28.0% margin

Operating Income

-$9M-25.7% margin

Net Income

-$15M-42.0% margin

EPS (Diluted)

$-0.47

QoQ Revenue Growth

+8.0%

Cash Flow

Operating Cash Flow

$1M

Free Cash Flow

-$4M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$238M

Total Liabilities

$235M

Stockholders' Equity

$2M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$35M	$36M	-1.5%
Gross Profit	$10M	$12M	-17.2%
Operating Income	-$9M	-$895,000	-908.8%
Net Income	-$15M	$16M	-194.5%